{"ticker": {"uuid": "65ca6b38-b1ef-466a-b90f-dcfbbc6c9a4d", "symbol": "4576", "name": "D. Western Therapeutics Institute, Inc.", "exchange": "JPX", "country": "JP", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "D. Western Therapeutics-Linked Glaucoma Eye Drop Launches in Malaysia", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxPc3I4dE9qY3N2a0xBbEtPdDh1YmZOd0lTM05UaTRIaFhuNEJZZUl5SUFNXzdXb2dndmVLRWhpTWw3MmVGUWRUWUpHX2FfT1BoUGFhTXlfbERrS3FYNk42UlFxbnk3SlNQZkJwWjJEWGhtV1dsREpaOVZlYlUta0F1dkdxLVNFMkI3SHpzSkRxSzk2UjZFaHUxUXYzMlFrVGYyMnE0OGhTeUQzY0ZpYWtn?oc=5", "source_name": "Moomoo", "published_at": "2025-12-16T08:00:00+00:00", "published_display": "16 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[Q&A session at end] Chordia Therapeutics to report interim U.S. trial results for rogocekib in mid-2026, targeting marketing approval filing by end of 2028", "summary": "", "url": "https://news.google.com/rss/articles/CBMiVkFVX3lxTE5jcVhsTU9RTnZBbkxEVDVMUE1QclVBb1pVUnNTSkp6cm4zOGlFQ1RhS0ZnNTA5LXo0cDd1dndqSFFBckE2NVYyUVFFRFk4VExndHVjNW5n?oc=5", "source_name": "\u30ed\u30b0\u30df\u30fcFinance", "published_at": "2025-10-30T07:00:00+00:00", "published_display": "30 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "D. Western Therapeutics-Linked Glaucoma Eye Drop Launches in Malaysia", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxPc3I4dE9qY3N2a0xBbEtPdDh1YmZOd0lTM05UaTRIaFhuNEJZZUl5SUFNXzdXb2dndmVLRWhpTWw3MmVGUWRUWUpHX2FfT1BoUGFhTXlfbERrS3FYNk42UlFxbnk3SlNQZkJwWjJEWGhtV1dsREpaOVZlYlUta0F1dkdxLVNFMkI3SHpzSkRxSzk2UjZFaHUxUXYzMlFrVGYyMnE0OGhTeUQzY0ZpYWtn?oc=5", "source_name": "Moomoo", "published_at": "2025-12-16T08:00:00+00:00", "published_display": "16 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[Q&A session at end] Chordia Therapeutics to report interim U.S. trial results for rogocekib in mid-2026, targeting marketing approval filing by end of 2028", "summary": "", "url": "https://news.google.com/rss/articles/CBMiVkFVX3lxTE5jcVhsTU9RTnZBbkxEVDVMUE1QclVBb1pVUnNTSkp6cm4zOGlFQ1RhS0ZnNTA5LXo0cDd1dndqSFFBckE2NVYyUVFFRFk4VExndHVjNW5n?oc=5", "source_name": "\u30ed\u30b0\u30df\u30fcFinance", "published_at": "2025-10-30T07:00:00+00:00", "published_display": "30 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 75, "total_relevant": 2, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 2, "score": 50, "total": 2, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 58, "events": [{"event": "general", "label": "Market update", "weight": 0.55, "count": 1}, {"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 81.0, "latest_week": "2026-07-10", "one_week_move": 2.5, "four_week_move": 19.1, "twelve_week_move": -13.8, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.964644, "market_dynamics_buy_signal": false, "relative_strength": -38.682245, "fair_value_gap": -29.9, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 36.3021, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+2.5% over one week, +19.1% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 50, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Moomoo", "count": 1}, {"label": "\u30ed\u30b0\u30df\u30fcFinance", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 2}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 1}, {"label": "Earnings", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "58/100 classification confidence."}, {"label": "Company focus", "value": "2", "tone": "neutral", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+2.5% over one week, +19.1% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "D. Western Therapeutics-Linked Glaucoma Eye Drop Launches in Malaysia"}], "updated_at": "2026-07-17T23:55:39.165653+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}